Is the US prepared to deal with another pandemic or widespread health crisis?
No, the US is not fully prepared for another pandemic or widespread health crisis, though it has made meaningful improvements since COVID-19 in some areas. Significant gaps in funding, workforce, coordination, stockpiles, supply chains, and sustained political commitment leave the country vulnerable, and recent policy shifts and cuts appear to have eroded some gains.[1][2]
Progress Since COVID-19
The US learned hard lessons from COVID-19 (over 1 million American deaths) and implemented reforms:
CDC testimony and ASPR updates highlight operational improvements in response structures (e.g., rapid stand-up for mpox/Marburg/H5N1) and a shift toward more cohesive, disease-agnostic readiness.[5]
Persistent and Growing Gaps
Experts, bipartisan commissions, GAO, and analyses consistently find the US underprepared:
Recent Developments (2025–2026) Have Raised Additional Concerns
Reports indicate significant erosion under the current administration:
ASPR continues some work (e.g., manufacturing onshoring, MCM approvals, H5N1 support), and multiyear budgets outline needs, but critics (including scientists and public health leaders) describe dismantling of key prevention/preparedness efforts.[19]
Bottom Line
The US has better tools, data systems, some stockpiles, and institutional knowledge than in 2019–2020, and it can handle smaller or contained outbreaks more effectively. However, it is not adequately prepared for a high-impact, novel, or rapidly spreading pandemic (respiratory virus or otherwise) on the scale of COVID or worse. Core issues—underinvestment in public health infrastructure, workforce attrition, coordination frictions, supply vulnerabilities, and boom-bust political attention—persist or have worsened recently. Bipartisan experts emphasize that pandemics are a national security issue requiring consistent, all-of-society investment rather than reactive spending.[1][12]
Readiness is dynamic: sustained funding, SLTT capacity-building, domestic manufacturing, trusted communication, and global cooperation would close gaps. Without them, another crisis would likely again reveal systemic weaknesses at high human and economic cost. Assessments from CDC, ASPR, GAO, WHO JEE, and independent commissions provide the primary evidence base; situations evolve with appropriations, outbreaks, and policy.
Citations (19)
- https://www.bmj.com/content/384/bmj.q332%20
Backs: “Significant gaps in funding, workforce, coordination, stockpiles, supply chains, and sustained political commitment leave the country vulnerable, and recent policy shifts and cuts appear to have eroded some gains.”
- https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/
Backs: “Significant gaps in funding, workforce, coordination, stockpiles, supply chains, and sustained political commitment leave the country vulnerable, and recent policy shifts and cuts appear to have eroded some gains.”
- https://www.presidency.ucsb.edu/documents/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response
Backs: “The Administration for Strategic Preparedness and Response (ASPR) continues leading medical countermeasures via BARDA and the Strategic National Stockpile (SNS).”
- https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2024/12/11/fact-sheet-biden-harris-administration-releases-global-health-security-annual-report-demonstrating-the-impact-of-united-states-leadership-and-investments/
Backs: “The Administration for Strategic Preparedness and Response (ASPR) continues leading medical countermeasures via BARDA and the Strategic National Stockpile (SNS).”
- https://www.cdc.gov/washington/testimony/2024/t20241114.htm
Backs: “The 2024 WHO Joint External Evaluation (JEE, using the post-COVID tool) showed strong capacities in areas like national laboratory systems, surveillance, reporting, emergency response operations, and immunization.”
- https://www.who.int/publications/i/item/9789240105409
Backs: “The 2024 WHO Joint External Evaluation (JEE, using the post-COVID tool) showed strong capacities in areas like national laboratory systems, surveillance, reporting, emergency response operations, and immunization.”
- https://extranet.who.int/sph/jee-united-states-america-conducted-0
Backs: “The 2024 WHO Joint External Evaluation (JEE, using the post-COVID tool) showed strong capacities in areas like national laboratory systems, surveillance, reporting, emergency response operations, and immunization.”
- https://www.aspr.gov/readiness-response/responses/asprs-response-h5n1-bird-flu
Backs: “Some H5N1 vaccines are licensed/stockpiled, with additional development (though some mRNA efforts faced later disruptions).”
- https://bidenwhitehouse.archives.gov/wp-content/uploads/2024/04/Global-Health-Security-Strategy-2024-1.pdf
Backs: “PAHPA (Pandemic and All-Hazards Preparedness Act) framework and PHEMCE provide structure, though funding shortfalls persist.”
- https://www.gao.gov/products/gao-24-106260
Backs: “Funding has not kept pace with expanded responsibilities; reliance on foreign/just-in-time supply chains remains a risk. PHEMCE multiyear needs have shown large shortfalls.”
- https://oig.hhs.gov/reports/all/2023/the-strategic-national-stockpile-was-not-positioned-to-respond-effectively-to-the-covid-19-pandemic/
Backs: “Funding has not kept pace with expanded responsibilities; reliance on foreign/just-in-time supply chains remains a risk. PHEMCE multiyear needs have shown large shortfalls.”
- https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/
Backs: “JEE recommendations emphasized better SLTT extension of capacities, alignment of frameworks, sustained investment, and workforce strengthening.”
- https://www.homelandsecuritynewswire.com/dr20230424-pandemic-preparedness-policy
Backs: “Global interdependence means domestic readiness depends partly on international capacity.”
- https://www.nytimes.com/2026/09/26/health/cdc-staff-cuts-rfk-jr.html
Backs: “Substantial CDC staffing reductions (estimates of ~18–30%+ losses via layoffs, resignations, retirements), impacting outbreak response, guidance, and data systems.”
- https://www.thinkglobalhealth.org/article/the-u-s-vaccine-pullback-is-a-strategic-mistake
Backs: “Withdrawal from the WHO, cuts or freezes to global health funding/partnerships (e.g., USAID elements, Gavi), and reduced international surveillance/coordination.”
- https://www.science.org/content/article/trump-administration-dismantling-efforts-fight-next-pandemic
Backs: “Reductions or wind-downs in biodefense/pandemic R&D (e.g., mRNA projects at BARDA/NIH/NIAID totaling hundreds of millions to over $1B affected), shifts away from certain pathogen research, and proposed/ enacted cuts to ASPR/BARDA/SNS/Hospital Preparedness Program funding in budget requests. COVID-era funds pulled from…”
- https://legalclarity.org/aspr-budget-fy-2026-cuts-reorganization-and-impacts/
Backs: “Reductions or wind-downs in biodefense/pandemic R&D (e.g., mRNA projects at BARDA/NIH/NIAID totaling hundreds of millions to over $1B affected), shifts away from certain pathogen research, and proposed/ enacted cuts to ASPR/BARDA/SNS/Hospital Preparedness Program funding in budget requests. COVID-era funds pulled from…”
- https://sph.brown.edu/news/2025-05-07/areweready
Backs: “Ongoing H5N1 monitoring and some stockpile use, but experts warn of weakened overall capacity amid concurrent threats (measles, mpox, others) and respiratory seasons.”
- https://www.aspr.gov/news-updates/blog/2025-12/stand-ready-move-fast-save-lives
Backs: “ASPR continues some work (e.g., manufacturing onshoring, MCM approvals, H5N1 support), and multiyear budgets outline needs, but critics (including scientists and public health leaders) describe dismantling of key prevention/preparedness efforts.”